| Literature DB >> 28420869 |
Lyudmila N Lysenkova1, Oleg Y Saveljev2, Natalya E Grammatikova1, Vladimir B Tsvetkov3,4,5, Olga B Bekker6, Valery N Danilenko6, Lyubov G Dezhenkova1, Eugene E Bykov1, Olga A Omelchuk1, Alexander M Korolev1, Andrey E Shchekotikhin1,7.
Abstract
Although, the structure of oligomycin A (1) was confirmed by spectroscopic and chemical evaluations, some crystallographic data cast doubt on the originally adopted structure of the side 2-hydroxypropyl moiety of this antibiotic. It was suggested that the side chain of the oligomycin is enol-related (2-hydroxy-1-propenyl). To clarify this matter we synthesized and evaluated 33-dehydrooligomycin A (2) prepared by the Kornblum oxidation of 33-O-mesyloligomycin A (3) by dimethyl sulfoxide. NMR data for 33-dehydrooligomycin (2) and results of quantum chemical calculations have shown that this derivative exists in the keto rather than in the enol tautomer 2a. The in vitro antimicrobial activity of 2 was approximately two times weaker in comparison with oligomycin A against Streptomyces fradiae ATCC-19609 and reference Candida spp. strains and similar activity against certain filamentous fungi. The docking binding estimate of 2 with FOF1ATP synthase showed a slight decrease in binding affinity for 2 when compared with oligomycin A; that correlated with its activity against S. fradiae ATCC 19609 that is supersensitive to oligomycin A. The in vitro antiproliferative activities of 2 are also discussed.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28420869 DOI: 10.1038/ja.2017.48
Source DB: PubMed Journal: J Antibiot (Tokyo) ISSN: 0021-8820 Impact factor: 2.649